4.10.3.2Vertical
Cochlear Implant Programs
Audiologists and surgeons providing cochlear implant therapy.
Market snapshot
These figures describe Audiology & Hearing Care (4.10.3), the segment that Cochlear Implant Programs sits within — not Cochlear Implant Programs on its own.
FragmentationConsolidatingEstimate
Within therapy/audiology offices (NAICS 621340) and ENT; the Census Bureau does not separate audiology, so the segment is not separately sized.
Business model & economics
Revenue model
Audiology services plus hearing-aid product margin
Key economics
- Recurring revenue
- Moderate
- EBITDA margin
- 15–25%
- Capex intensity
- Low
replacement cycles and follow-up care
Characteristics
- Blends clinical audiology with hearing-aid sales.
- OTC hearing aids pressure the dispensing model.
- Aging-related hearing loss drives demand.
M&A deal context
Deal activityModerate
Who’s acquiring
- Hearing-care networks
- ENT & audiology MSOs
- Hearing-device & retail strategics
What’s driving deals
- Consolidation of hearing-care networks.
- OTC hearing-aid disruption.
- Aging-related hearing-loss demand.
Find Cochlear Implant Programs acquisition targets
Search Acquisera’s index for companies classified under Cochlear Implant Programs (4.10.3.2) and build a targeted deal pipeline.
Search companies